Trinity Biotech Plc Stock Price on November 15, 2024
| TRIB Stock | USD 1.10 0.02 1.79% |
Below is the normalized historical share price chart for Trinity Biotech plc extending back to October 21, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Trinity Biotech stands at 1.10, as last reported on the 1st of December, with the highest price reaching 1.15 and the lowest price hitting 1.09 during the day.
If you're considering investing in Trinity Stock, it is important to understand the factors that can impact its price. Trinity Biotech plc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0969, which indicates the firm had a -0.0969% return per unit of risk over the last 3 months. Trinity Biotech plc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Trinity Biotech's Variance of 37.88, coefficient of variation of (731.63), and Risk Adjusted Performance of (0.1) to confirm the risk estimate we provide.
At present, Trinity Biotech's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.04, whereas Total Stockholder Equity is projected to grow to (22.8 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 0.28. Trinity Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of August 1995 | 200 Day MA 2.0009 | 50 Day MA 1.5018 | Beta 1.133 |
Trinity |
Sharpe Ratio = -0.0969
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TRIB |
Estimated Market Risk
| 6.08 actual daily | 54 54% of assets are less volatile |
Expected Return
| -0.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Trinity Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trinity Biotech by adding Trinity Biotech to a well-diversified portfolio.
Price Book 5.1132 | Enterprise Value Ebitda (6.06) | Price Sales 0.5193 | Shares Float 95.9 M | Wall Street Target Price 3 |
Trinity Biotech Main Headline on 15th of November 2024
Trinity Biotech Announces Q3 2024 Financial Results by globenewswire.com
Q3 2024 total revenue of 15.2 million grew 3 percent YY based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of 4.3...
Trinity Biotech Valuation on November 15, 2024
It is possible to determine the worth of Trinity Biotech on a given historical date. On November 15, 2024 Trinity was worth 1.34 at the beginning of the trading date compared to the closed value of 1.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Trinity Biotech stock. Still, in general, we apply an absolute valuation method to find Trinity Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Trinity Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Trinity Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 1.53 | 1.66 | 1.30 | 1.48 | 57,289 | |
11/15/2024 | 1.34 | 1.53 | 1.34 | 1.37 | 51,631 |
| 1.32 | 1.44 | 1.24 | 1.30 | 102,394 |
| Backtest Trinity Biotech | | | Trinity Biotech History | | | Trinity Biotech Valuation | Previous | Next |
Trinity Biotech Trading Date Momentum on November 15, 2024
| On November 18 2024 Trinity Biotech plc was traded for 1.30 at the closing time. The top price for the day was 1.44 and the lowest listed price was 1.24 . The trading volume for the day was 102.4 K. The trading history from November 18, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 5.11% . The trading price change against the current closing price is 13.87% . |
Trinity Biotech plc Fundamentals Correlations and Trends
By evaluating Trinity Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Trinity Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Trinity financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Trinity Biotech Stock history
Trinity Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Trinity is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Trinity Biotech plc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Trinity Biotech stock prices may prove useful in developing a viable investing in Trinity Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7.7 M | 6.8 M | |
| Net Income Applicable To Common Shares | 787.5 K | 826.9 K |
Trinity Biotech Stock Technical Analysis
Trinity Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Trinity Biotech Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Trinity Biotech plc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Trinity Biotech December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Trinity Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Trinity Biotech shares will generate the highest return on investment. By undertsting and applying Trinity Biotech stock market strength indicators, traders can identify Trinity Biotech plc entry and exit signals to maximize returns
Trinity Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Trinity Biotech's price direction in advance. Along with the technical and fundamental analysis of Trinity Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Trinity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (1.88) | |||
| Treynor Ratio | (10.75) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Trinity Stock analysis
When running Trinity Biotech's price analysis, check to measure Trinity Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Biotech is operating at the current time. Most of Trinity Biotech's value examination focuses on studying past and present price action to predict the probability of Trinity Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trinity Biotech's price. Additionally, you may evaluate how the addition of Trinity Biotech to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance |